Article info
Research letter
Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis
- Correspondence to Dr Marc Tebruegge, NIHR Wellcome Trust Clinical Research Facility (Mailpoint 218), University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton SO16 6YD, UK; m.tebruegge{at}soton.ac.uk
Citation
Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis
Publication history
- Received September 7, 2016
- Revised December 19, 2016
- Accepted January 12, 2017
- First published February 3, 2017.
Online issue publication
September 01, 2022
Article Versions
- Previous version (13 September 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/